[go: up one dir, main page]

ES2111083T3 - Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno). - Google Patents

Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno).

Info

Publication number
ES2111083T3
ES2111083T3 ES92920802T ES92920802T ES2111083T3 ES 2111083 T3 ES2111083 T3 ES 2111083T3 ES 92920802 T ES92920802 T ES 92920802T ES 92920802 T ES92920802 T ES 92920802T ES 2111083 T3 ES2111083 T3 ES 2111083T3
Authority
ES
Spain
Prior art keywords
compositions containing
quinolones
stirene
sulphonate
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92920802T
Other languages
English (en)
Inventor
Yusuf Ali
Rajni Jani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Application granted granted Critical
Publication of ES2111083T3 publication Critical patent/ES2111083T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES FARMACEUTICAS ACUOSAS CONTENIENDO UNA COMBINACION SINERGICA DE UNA QUINOLONA Y UN POLIMERO ACIDO SULFONICO DE POLIESTIRENO, DONDE LAS COMPOSICIONES SON SOLUCIONES LIMPIAS QUE RESULTAN CONFORTABLES Y TIENEN LIBERACION SOSTENIDA. SE DESCRIBEN METODOS PARA USO DE LAS COMPOSICIONES. ESTE TIPO DE FORMULACION ES PARTICULARMENTE UTIL CON QUINOLONAS DEL TIPO DE CIPROFLOXACINA, AUMENTANDO CONSIDERABLEMENTE LA SOLUBILIDAD DE ESTAS QUINOLONAS, HACIENDO FACTIBLE PODER TENER SOLUCIONES ACUOSAS QUE CONTIENEN TALES QUINOLONAS EN, O CERCA DE, PH FISIOLOGICO.
ES92920802T 1991-09-17 1992-09-11 Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno). Expired - Lifetime ES2111083T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76110491A 1991-09-17 1991-09-17

Publications (1)

Publication Number Publication Date
ES2111083T3 true ES2111083T3 (es) 1998-03-01

Family

ID=25061139

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92920802T Expired - Lifetime ES2111083T3 (es) 1991-09-17 1992-09-11 Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno).

Country Status (9)

Country Link
US (1) US5679336A (es)
EP (1) EP0604570B1 (es)
AT (1) ATE162081T1 (es)
AU (1) AU2672892A (es)
DE (1) DE69224071T2 (es)
DK (1) DK0604570T3 (es)
ES (1) ES2111083T3 (es)
GR (1) GR3026209T3 (es)
WO (1) WO1993005816A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2106680B1 (es) * 1995-08-03 1998-07-01 Vita Invest Sa Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
US5695882A (en) * 1995-08-17 1997-12-09 The University Of Montana System for extracting soluble heavy metals from liquid solutions
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
US6270755B1 (en) * 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
EP1800686A3 (en) * 1999-05-13 2009-12-30 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
US6290946B1 (en) 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
NZ516536A (en) * 1999-07-14 2003-09-26 Schering Plough Ltd Taste masking or oral quinolone liquid preparations using ion exchange resins
US6514492B1 (en) 1999-07-14 2003-02-04 Schering-Plough Veterinary Corporation Taste masking of oral quinolone liquid preparations using ion exchange resins
PL201130B1 (pl) 1999-09-24 2009-03-31 Alcon Inc Kompozycje zawiesinowe zawierające ciprofloksacynę i deksametazon do podawania miejscowego do oczu, uszu lub nosa
EP1225898B1 (en) * 1999-11-01 2003-06-18 Alcon Inc. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
CA2314494A1 (en) 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Anionic polymers as species specific antibacterial agents
PT1305033E (pt) 2000-07-28 2005-01-31 Alcon Inc Composicoes farmaceuticas que contem tobramicina e goma de xantano
US6743439B1 (en) * 2001-06-27 2004-06-01 Alcon, Inc. Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride
CA2459930C (en) 2001-09-21 2009-11-10 Alcon, Inc. Method of treating middle ear infections
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
CN105362256A (zh) * 2009-02-18 2016-03-02 阿拉迪姆公司 pH调节的肺部给药制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
US4292317A (en) * 1977-09-20 1981-09-29 Laboratorie Roger Bellon 1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4615882A (en) * 1982-09-27 1986-10-07 Stockel Richard F Disinfectant solution for contact lens
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung

Also Published As

Publication number Publication date
DE69224071D1 (de) 1998-02-19
DE69224071T2 (de) 1998-05-07
DK0604570T3 (da) 1998-09-14
AU2672892A (en) 1993-04-27
US5679336A (en) 1997-10-21
EP0604570A1 (en) 1994-07-06
WO1993005816A1 (en) 1993-04-01
GR3026209T3 (en) 1998-05-29
EP0604570B1 (en) 1998-01-14
ATE162081T1 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
ES2111083T3 (es) Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno).
DK354785D0 (da) Stabile salte af s-adenosyl-l-methionin med polyanioner
ATE376423T1 (de) Gelierende wässrige pharmazeutische zusammensetzungen
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
CA2447924A1 (en) Olopatadine formulations for topical administration
ATE242783T1 (de) Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
ATE248837T1 (de) Chinuclidin-acrylamide
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
DE68901153D1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
BR0005915A (pt) Comprimido matriz que possibilita a liberação prolongada de trimetazidina após a administração pela via oral
DK0866791T3 (da) Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
ATE259813T1 (de) Triazolopyrimidinderivate
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
ES2195819T3 (es) Formulaciones oftalmicas acuosas antibacterianas que contiene ofloxacino y chitosan.
PT1178960E (pt) Analogos da vitamina d e sua utilizacao farmaceutica
MXPA02003731A (es) Derivados novedosos de acido fusidico.
NO20053876L (no) Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 604570

Country of ref document: ES